New Microbial Testing Lab Expansion at Pace(R) Life Sciences

Audio By Carbonatix

Expanded microbial limits testing lab in Lebanon, NJ boosts capacity and strengthens analytical services

LEBANON, NJ / ACCESS Newswire / April 2, 2026 / Pace® Life Sciences, a U.S.-based contract development and manufacturing organization (CDMO) and a division of Pace®, a Science and Technology Company announced today the opening of its newly expanded microbial limits testing laboratory at its Lebanon, New Jersey facility, further strengthening the site's comprehensive analytical service offerings.

This upgraded space significantly increases throughput, efficiency, and reliability within an already well‑established microbial limits testing program. With the added capacity, the team can now support higher sample volumes while continuing to uphold the highest standards of quality and regulatory compliance delivering on the organization's ongoing commitment to product quality, patient safety, and operational excellence.

"This expansion is another step forward in enhancing the depth and breadth of services we offer our clients," said Amanda Yoakum, Site Head in Lebanon, NJ. "By investing in both infrastructure and expertise, we are ensuring that our Lebanon facility continues to deliver the speed, scientific rigor, and reliability our partners depend on."

The Lebanon, NJ site is a full-service analytical testing lab that supports a wide range of services, including analytical chemistry, microbiology, sterility testing, container closure integrity testing (CCIT), and packaging and delivery system evaluations. The facility also plays a crucial role in advancing small and large molecule programs from early development through commercialization.

Pace® is a portfolio company of Leonard Green & Partners and Los Angeles-based Aurora Capital Partners.

###

ABOUT PACE® LIFE SCIENCES

Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries. Our network of CDMO sites consists of GMP analytical testing laboratories and manufacturing support service centers. Our experienced, highly trained industry experts and our investment in state-of-the-art development and manufacturing facilities emphasize our commitment to efficiently advancing client programs through the clinic to commercialization. We are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business. More at www. .

ABOUT PACE®

Pace® makes the world a safer, healthier place. Pace® people are committed to advancing the science of the pharmaceutical and biotechnology industries in our Life sciences laboratories and supporting businesses, industries, consulting firms, government agencies, and more in our Analytical Services Laboratories. Pace® offers local-level service backed by a national laboratory network. For customers with in-house labs, Pace® provides a range of professional services to keep their operations moving forward. Pace® people work in partnership with customers by providing the service, science and data they need to make critical decisions that benefit us all.

View the original press release on ACCESS Newswire